Cholesin receptor signalling is active in cardiovascular system-associated adipose tissue and correlates with SGLT2i treatment in patients with diabetes.
Aleksandra RykAnna MarcinkiewiczJędrzej ChrzanowskiArkadiusz Mariusz MichalakIzabela DróżdżJacek BurzyńskiMichał KrejcaWojciech FendlerPublished in: Cardiovascular diabetology (2024)
GPR146 expression is associated with serum lipids and metabolically-relevant transcriptomic changes in EAT similar to SGLT2i-associated ones.